The Mikamo Lecture 2002. Therapeutic targets for the treatment of atherothrombosis in the new millennium--clinical frontiers in atherosclerosis research.

pathologic mechanism, and the availability of effective diagnostic and treatment modalities, atherosclerosis remains the leading cause of mortality and morbidity. New findings have recently introduced exciting concepts that could have a major impact on the treatment of the atherosclerotic disease. Some of these concepts derive from in vivo observations using new imaging technologies, such as high-resolution magnetic resonance imaging (MRI). We will discuss the mechanisms that lead to the development of atherosclerosis and those responsible for the acute coronary syndromes (ACS).

[1]  E. Ritman,et al.  Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[2]  V. Fuster,et al.  In vivo noninvasive detection and age definition of arterial thrombus by MRI. , 2002, Journal of the American College of Cardiology.

[3]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[4]  G. Franceschini,et al.  Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[6]  V. Fuster,et al.  Increased circulating tissue factor and blood thrombogenicity in Type-2 diabetes , 2002 .

[7]  V. Fuster,et al.  Increased incidence of internal elastic lamina rupture and intimal medial changes in complex atherosclerotic lesions: understanding the remodeling paradox and plaque disruption , 2002 .

[8]  P J de Feyter,et al.  New coronary imaging techniques: what to expect? , 2002, Heart.

[9]  Zahi A Fayad,et al.  Progression and Regression of Atherosclerotic Lesions: Monitoring With Serial Noninvasive Magnetic Resonance Imaging , 2002, Circulation.

[10]  V. Fuster,et al.  Strategy for ensuring a better future for the vessel wall , 2002 .

[11]  E. Ritman,et al.  Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.

[12]  Renu Virmani,et al.  Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis , 2002, Circulation.

[13]  G. Helft,et al.  Coronary artery imaging in the new millennium. , 2002, Heart, lung & circulation.

[14]  René M. Botnar,et al.  Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.

[15]  J. Badimón,et al.  Value or desirability of hemorheological-hemostatic parameter changes as endpoints in blood lipid-regulating trials , 2001, Current opinion in lipidology.

[16]  V. Fuster,et al.  New Understanding of Atherosclerosis (Clinically and Experimentally) with Evolving MRI Technology in Vivo , 2001, Annals of the New York Academy of Sciences.

[17]  S. Kaul,et al.  Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II , 2001, Circulation.

[18]  Jan Nilsson,et al.  Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I , 2001, Circulation.

[19]  V. Fuster,et al.  Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. , 2001, Journal of the American College of Cardiology.

[20]  J. Rouleau,et al.  Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease? , 2001, Circulation.

[21]  E. Ritman,et al.  Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular Research.

[22]  F. Lupu,et al.  Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[23]  V. Fuster,et al.  Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.

[24]  V. Fuster,et al.  Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.

[25]  Peter Libby,et al.  Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.

[26]  A. Tedgui,et al.  Current perspective on the role of apoptosis in atherothrombotic disease. , 2001, Circulation research.

[27]  P. Libby,et al.  Evolution and stabilization of vulnerable atherosclerotic plaques. , 2001, Japanese circulation journal.

[28]  V. Fuster,et al.  Artery dissection and arterial thrombus aging: the role of noninvasive magnetic resonance imaging. , 2001, Circulation.

[29]  A. Tedgui,et al.  Anti-Inflammatory Mechanisms in the Vascular Wall , 2001, Circulation research.

[30]  Y. Geng.  Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis , 2001, Current atherosclerosis reports.

[31]  P. Libby,et al.  Inflammation and thrombosis: the clot thickens. , 2001, Circulation.

[32]  J. Ware,et al.  Too many vessels? Not enough? The wrong kind? The VEGF debate continues. , 2001, Nature Medicine.

[33]  V. Fuster,et al.  Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. , 2001, Journal of the American College of Cardiology.

[34]  Matthijs Oudkerk,et al.  Coronary angiography with multi-slice computed tomography , 2001, The Lancet.

[35]  B J McNeil,et al.  Advances in biomedical imaging. , 2001, JAMA.

[36]  W. Hsueh,et al.  Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. , 2001, Diabetes care.

[37]  P. Yock,et al.  Intravascular ultrasound: novel pathophysiological insights and current clinical applications. , 2001, Circulation.

[38]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[39]  Werner Moshage,et al.  Noninvasive Coronary Angiography by Retrospectively ECG-Gated Multislice Spiral CT , 2000, Circulation.

[40]  A. Tedgui,et al.  Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[41]  V. Fuster,et al.  Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. , 2000, Journal of the American College of Cardiology.

[42]  René M. Botnar,et al.  Noninvasive Coronary Vessel Wall and Plaque Imaging With Magnetic Resonance Imaging , 2000, Circulation.

[43]  M F Reiser,et al.  Current development of cardiac imaging with multidetector-row CT. , 2000, European journal of radiology.

[44]  V. Fuster,et al.  Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. , 2000, Atherosclerosis.

[45]  Samin K. Sharma,et al.  Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. , 2000, Circulation.

[46]  E Falk,et al.  Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? , 2000, Journal of the American College of Cardiology.

[47]  V. Fuster,et al.  Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. , 2000, The American journal of cardiology.

[48]  D. Grönemeyer,et al.  Usefulness of topography of coronary calcium by electron-beam computed tomography in predicting the natural history of coronary atherosclerosis. , 2000, The American journal of cardiology.

[49]  V. Fuster,et al.  Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. , 2000, Circulation.

[50]  V. Fuster,et al.  High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. , 2000, Atherosclerosis.

[51]  V. Fuster,et al.  In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. , 2000, Circulation.

[52]  A. Tedgui,et al.  CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.

[53]  Y. Nemerson,et al.  Tissue factor, the blood, and the arterial wall. , 2000, Trends in cardiovascular medicine.

[54]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[55]  J. Badimón,et al.  The role of plaque rupture and thrombosis in coronary artery disease. , 2000, Atherosclerosis.

[56]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[57]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[58]  J. Fujimoto,et al.  Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound. , 2000, The American journal of cardiology.

[59]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[60]  T. Callister,et al.  Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. , 2000, Circulation.

[61]  V. Fuster,et al.  Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. , 2000, Circulation.

[62]  V. Pasceri,et al.  Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. , 2000, Circulation.

[63]  J. Badimón,et al.  Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. , 2000, Blood.

[64]  V. Fuster,et al.  The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[65]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[66]  K. Kugiyama,et al.  Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. , 1999, Circulation.

[67]  Zahi A Fayad,et al.  Acute coronary syndromes: biology , 1999, The Lancet.

[68]  V. Fuster,et al.  Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. , 1999, Circulation.

[69]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[70]  P. Libby,et al.  PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression PPARγ as a Potential Mediator in Vascular Disease , 1999 .

[71]  T. Watanabe,et al.  Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function. , 1999, Biochemical and biophysical research communications.

[72]  P. Libby,et al.  PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[73]  C Yuan,et al.  Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. , 1998, Circulation.

[74]  E A Fisher,et al.  Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. , 1998, Circulation.

[75]  A. Gallino,et al.  Spiral computed tomography: a novel diagnostic approach for investigation of the extracranial cerebral arteries and its complementary role in duplex ultrasonography. , 1998, Circulation.

[76]  T. Callister,et al.  Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.

[77]  S M Jorgensen,et al.  Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. , 1998, The American journal of physiology.

[78]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[79]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[80]  B. Seed,et al.  PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. , 1998, Nature.

[81]  V. Fuster,et al.  Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[82]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[83]  V. Fuster,et al.  Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.

[84]  G Baumann,et al.  Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. , 1996, Journal of the American College of Cardiology.

[85]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[86]  M. Budoff,et al.  Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. , 1996, Journal of the American College of Cardiology.

[87]  G. Hutchins,et al.  Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. , 1995, Journal of the American College of Cardiology.

[88]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[89]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[90]  V. Fuster,et al.  Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. , 1994, Circulation.

[91]  V. Fuster,et al.  Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.

[92]  J F Martin,et al.  Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[93]  A. Roos,et al.  Magnetic Resonance Imaging in Coronary Artery Disease , 2012, Developments in Cardiovascular Medicine.

[94]  S. Moncada,et al.  Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis , 1991, European journal of clinical investigation.

[95]  R. M. Lee,et al.  Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. , 1990, Atherosclerosis.

[96]  V. Fuster,et al.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.

[97]  Y. Nemerson.  Tissue factor and hemostasis. , 1988, Blood.

[98]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.